Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease

Summary Background Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. Aim To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endo...

Full description

Saved in:
Bibliographic Details
Published inAlimentary pharmacology & therapeutics Vol. 46; no. 2; pp. 175 - 182
Main Authors Pang, J., Xu, W., Zhang, X., Wong, G. L.‐H., Chan, A. W.‐H., Chan, H.‐Y., Tse, C.‐H., Shu, S. S.‐T., Choi, P. C.‐L., Chan, H. L.‐Y., Yu, J., Wong, V. W.‐S.
Format Journal Article
LanguageEnglish
Published England Wiley Subscription Services, Inc 01.07.2017
Subjects
Online AccessGet full text
ISSN0269-2813
1365-2036
1365-2036
DOI10.1111/apt.14119

Cover

Loading…
Abstract Summary Background Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. Aim To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia. Methods The endotoxemia markers lipopolysaccharide‐binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity. Results A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2‐4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin‐18 fragments (P=.002) and aspartate aminotransferase‐to‐alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2‐4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level. Conclusions Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target. Linked ContentThis article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154.
AbstractList Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia. The endotoxemia markers lipopolysaccharide-binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity. A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2-4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin-18 fragments (P=.002) and aspartate aminotransferase-to-alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2-4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level. Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target.
BackgroundPatients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.AimTo test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.MethodsThe endotoxemia markers lipopolysaccharide‐binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.ResultsA total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2‐4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin‐18 fragments (P=.002) and aspartate aminotransferase‐to‐alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2‐4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.ConclusionsEndotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target.
Summary Background Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. Aim To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia. Methods The endotoxemia markers lipopolysaccharide‐binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity. Results A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2‐4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin‐18 fragments (P=.002) and aspartate aminotransferase‐to‐alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2‐4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level. Conclusions Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target. Linked ContentThis article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154.
Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.BACKGROUNDPatients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.To test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.AIMTo test the hypothesis that endotoxemia is associated with the histological severity of nonalcoholic fatty liver disease (NAFLD) and determine factors associated with endotoxemia.The endotoxemia markers lipopolysaccharide-binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.METHODSThe endotoxemia markers lipopolysaccharide-binding protein (LBP) and endotoxin levels were measured in 237 NAFLD patients 1 day before liver biopsy. Biomarkers of liver injury and transient elastography were performed as additional markers of disease severity.A total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2-4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin-18 fragments (P=.002) and aspartate aminotransferase-to-alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2-4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.RESULTSA total of 114/237 (48%) patients had NASH and 80/237 (34%) had F2-4 fibrosis. LBP was correlated with lobular inflammation (P=.001), while both LBP (P=.0004) and endotoxin levels (P=0.008) were correlated with fibrosis. LBP was also correlated with cytokeratin-18 fragments (P=.002) and aspartate aminotransferase-to-alanine aminotransferase ratio (P=.006), and both LBP (P=.019) and endotoxin (P=.006) were correlated with liver stiffness measurement by transient elastography. LBP was increased in patients with NASH (15.3±4.6 vs 13.8±3.3 μg/mL; P=.005) and F2-4 fibrosis (15.4±4.4 vs 14.0±3.7 μg/mL; P=.008). Interestingly, patients harbouring the TM6SF2 rs58542926 T allele that predispose to NAFLD/NASH had higher LBP level. By multivariate analysis, gender, higher body mass index and glycated haemoglobin, and TM6SF2 variants were independent factors associated with increased LBP level.Endotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target.CONCLUSIONSEndotoxemia is positively associated with NASH and significant fibrosis. The association between TM6SF2 and endotoxemia warrants further investigations. The findings may shed light on the pathogenesis of NASH and inform a novel treatment target.
Linked Content This article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154 .
Author Yu, J.
Choi, P. C.‐L.
Xu, W.
Chan, A. W.‐H.
Chan, H.‐Y.
Tse, C.‐H.
Wong, V. W.‐S.
Zhang, X.
Pang, J.
Shu, S. S.‐T.
Chan, H. L.‐Y.
Wong, G. L.‐H.
Author_xml – sequence: 1
  givenname: J.
  surname: Pang
  fullname: Pang, J.
  organization: The Chinese University of Hong Kong
– sequence: 2
  givenname: W.
  surname: Xu
  fullname: Xu, W.
  organization: The Chinese University of Hong Kong
– sequence: 3
  givenname: X.
  surname: Zhang
  fullname: Zhang, X.
  organization: The Chinese University of Hong Kong
– sequence: 4
  givenname: G. L.‐H.
  orcidid: 0000-0002-2863-9389
  surname: Wong
  fullname: Wong, G. L.‐H.
  organization: The Chinese University of Hong Kong
– sequence: 5
  givenname: A. W.‐H.
  surname: Chan
  fullname: Chan, A. W.‐H.
  organization: The Chinese University of Hong Kong
– sequence: 6
  givenname: H.‐Y.
  surname: Chan
  fullname: Chan, H.‐Y.
  organization: The Chinese University of Hong Kong
– sequence: 7
  givenname: C.‐H.
  surname: Tse
  fullname: Tse, C.‐H.
  organization: The Chinese University of Hong Kong
– sequence: 8
  givenname: S. S.‐T.
  surname: Shu
  fullname: Shu, S. S.‐T.
  organization: The Chinese University of Hong Kong
– sequence: 9
  givenname: P. C.‐L.
  surname: Choi
  fullname: Choi, P. C.‐L.
  organization: The Chinese University of Hong Kong
– sequence: 10
  givenname: H. L.‐Y.
  surname: Chan
  fullname: Chan, H. L.‐Y.
  organization: The Chinese University of Hong Kong
– sequence: 11
  givenname: J.
  surname: Yu
  fullname: Yu, J.
  email: junyu@cuhk.edu.hk
  organization: The Chinese University of Hong Kong
– sequence: 12
  givenname: V. W.‐S.
  orcidid: 0000-0003-2215-9410
  surname: Wong
  fullname: Wong, V. W.‐S.
  email: wongv@cuhk.edu.hk
  organization: The Chinese University of Hong Kong
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28464257$$D View this record in MEDLINE/PubMed
BookMark eNp1kctuFDEQRS0URCaBBT-ALLGBRSd-tbt7GUW8pEggEdaW21OdqchjN7YnyeyQ-AG-kS_BZCabCLypzTnXpbpH5CDEAIS85OyE13dq53LCFefDE7LgUreNYFIfkAUTemhEz-UhOcr5mjGmOyaekUPRK61E2y3Iz694FXBCZ0Ohc8xY8AaozTk6tAVjoHGiEJaxxDtYo6W3WFZ0hblEH6-q5mmGG0hYthQDFbKjc_UglLxD66q_f_yy3sVV9OjoZEtFff0l0SVmsBmek6eT9Rle7Ocx-fb-3eX5x-bi84dP52cXjZN9PzSOy1GDsy1XfSdB8b5Oq0F2amy5nqQcB-gUB-E6oUDJltvROjEoJkBOnTwmb3a5c4rfN5CLWWN24L0NEDfZ8H5QA--l1hV9_Qi9jpsU6naGD0IopXjHKvVqT23GNSzNnHBt09Y8nLcCpzvApZhzgsk4LPdnLcmiN5yZvwWaWqC5L7Aabx8ZD6H_Yvfpt-hh-3_QnH253Bl_AEj1q-Y
CitedBy_id crossref_primary_10_1007_s11892_020_01342_8
crossref_primary_10_1155_2019_8507583
crossref_primary_10_3389_fendo_2020_613639
crossref_primary_10_1038_s41598_019_45009_1
crossref_primary_10_1055_s_0041_1723752
crossref_primary_10_1088_1755_1315_1371_6_062022
crossref_primary_10_1128_spectrum_05230_22
crossref_primary_10_1007_s12072_020_10081_7
crossref_primary_10_1016_j_phanu_2020_100213
crossref_primary_10_1038_s41575_021_00472_y
crossref_primary_10_1016_j_jacbts_2023_07_003
crossref_primary_10_1038_s41591_022_01850_y
crossref_primary_10_1002_jev2_12303
crossref_primary_10_1016_j_smim_2023_101859
crossref_primary_10_1002_hep_30908
crossref_primary_10_1111_ijpo_13091
crossref_primary_10_1177_20420188241242937
crossref_primary_10_1111_dom_15014
crossref_primary_10_1111_1751_2980_12845
crossref_primary_10_3390_ijms221910470
crossref_primary_10_1007_s12275_022_2087_y
crossref_primary_10_1038_s41575_018_0009_6
crossref_primary_10_3390_nu11081712
crossref_primary_10_1016_j_jcmgh_2023_09_002
crossref_primary_10_1111_jam_14992
crossref_primary_10_1038_s41577_019_0198_4
crossref_primary_10_1038_s42255_024_01156_y
crossref_primary_10_1016_j_joim_2021_07_004
crossref_primary_10_3390_ijms21041525
crossref_primary_10_1111_eci_14224
crossref_primary_10_1016_j_trsl_2020_11_003
crossref_primary_10_1016_j_lfs_2023_121614
crossref_primary_10_1016_j_jhepr_2019_09_001
crossref_primary_10_3390_microorganisms8111744
crossref_primary_10_1002_kjm2_12904
crossref_primary_10_1111_liv_14571
crossref_primary_10_1016_j_omtn_2022_08_003
crossref_primary_10_1111_apt_14154
crossref_primary_10_3390_cells9010037
crossref_primary_10_1097_MPG_0000000000002111
crossref_primary_10_1371_journal_pmed_1002894
crossref_primary_10_1016_j_bbrc_2020_08_036
crossref_primary_10_1016_j_cmet_2024_05_008
crossref_primary_10_3390_cancers15010023
crossref_primary_10_25040_lkv2022_03_04_008
crossref_primary_10_3390_diseases7010027
crossref_primary_10_1038_ijo_2017_162
crossref_primary_10_3389_fendo_2023_1196831
crossref_primary_10_1007_s12072_021_10286_4
crossref_primary_10_1111_1751_2980_12709
crossref_primary_10_31146_1682_8658_ecg_185_1_4_52
crossref_primary_10_1111_jgh_15729
crossref_primary_10_1016_j_jksus_2020_03_019
crossref_primary_10_3390_nu14245261
crossref_primary_10_1016_j_tem_2022_01_002
crossref_primary_10_1097_QAD_0000000000002133
crossref_primary_10_5694_mja17_01067
crossref_primary_10_1038_s42255_024_01177_7
crossref_primary_10_1002_hep_31056
crossref_primary_10_3390_nu10111793
Cites_doi 10.1038/nature11053
10.1136/gutjnl-2015-309265
10.1016/S1665-2681(19)31364-X
10.1053/j.gastro.2016.01.005
10.1111/apt.12569
10.1073/pnas.1323785111
10.1126/science.1208344
10.1002/hep.23312
10.1073/pnas.0407076101
10.1111/j.1572-0241.2001.03702.x
10.1074/jbc.M116.719955
10.1111/apt.13327
10.1016/j.jhep.2011.12.025
10.1007/s11695-007-9243-7
10.1002/hep.28142
10.1002/hep.27556
10.1002/hep.25762
10.1111/apt.12609
10.1038/76048
10.1186/1476-9255-7-15
10.1038/ng.257
10.1136/gut.2009.205088
10.1016/j.cgh.2014.04.014
10.1002/hep.28475
10.1002/hep.26299
10.1371/journal.pgen.1001324
10.1111/apt.13833
10.1016/j.jhep.2014.04.047
10.2337/db09-0367
10.1038/ng.2901
10.1002/hep.26093
10.1002/hep.28572
10.2337/db07-1403
10.1002/hep.28356
10.1002/hep.20701
10.1002/hep.22848
10.1053/j.gastro.2012.01.034
10.1016/j.jhep.2008.05.025
10.1002/hep.27490
10.1002/hep.28697
10.1111/apt.13232
10.1111/j.1462-5822.2006.00796.x
10.1007/s00125-007-0791-0
10.1053/j.gastro.2010.11.049
10.1016/0168-8278(91)90933-3
10.1038/ng.2926
10.3748/wjg.v19.i40.6911
10.1371/journal.pone.0062885
10.1038/nature13398
ContentType Journal Article
Copyright 2017 John Wiley & Sons Ltd
2017 John Wiley & Sons Ltd.
Copyright © 2017 John Wiley & Sons Ltd
Copyright_xml – notice: 2017 John Wiley & Sons Ltd
– notice: 2017 John Wiley & Sons Ltd.
– notice: Copyright © 2017 John Wiley & Sons Ltd
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7U9
H94
K9.
M7N
7X8
DOI 10.1111/apt.14119
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Immunology Abstracts
Neurosciences Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Immunology Abstracts
Virology and AIDS Abstracts
Neurosciences Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
MEDLINE - Academic
DatabaseTitleList MEDLINE
AIDS and Cancer Research Abstracts

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1365-2036
EndPage 182
ExternalDocumentID 28464257
10_1111_apt_14119
APT14119
Genre article
Journal Article
GrantInformation_xml – fundername: Food and Health Bureau of the Hong Kong SAR Government
  funderid: 11120621
GroupedDBID ---
.3N
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
23M
24P
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
6J9
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AAHQN
AAIPD
AAKAS
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABJNI
ABOCM
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZCM
ADZMN
ADZOD
AEEZP
AEGXH
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFRAH
AFWVQ
AFZJQ
AHBTC
AHEFC
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
D-6
D-7
D-E
D-F
DC6
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DTERQ
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EBX
EJD
EMB
EMK
EMOBN
EST
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FZ0
G-S
G.N
GODZA
GX1
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK0
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
P6G
PALCI
Q.N
Q11
QB0
Q~Q
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
SV3
TEORI
TR2
TUS
UB1
V8K
V9Y
W8V
W99
WBKPD
WH7
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
XG1
YOC
ZZTAW
~IA
~WT
AAYXX
AGHNM
AGQPQ
AGYGG
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7T5
7TK
7U9
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
H94
K9.
M7N
7X8
ID FETCH-LOGICAL-c3889-c13b6eca514873e418487a6e374b516f33b9e741e2c724e4351abac29402e3f73
IEDL.DBID DR2
ISSN 0269-2813
1365-2036
IngestDate Fri Jul 11 06:52:06 EDT 2025
Fri Jul 25 10:09:13 EDT 2025
Wed Feb 19 02:43:51 EST 2025
Tue Jul 01 02:22:19 EDT 2025
Thu Apr 24 23:04:53 EDT 2025
Wed Jan 22 16:42:45 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2017 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3889-c13b6eca514873e418487a6e374b516f33b9e741e2c724e4351abac29402e3f73
Notes Linked Content
The Handling Editor for this article was Professor Stephen Harrison, and it was accepted for publication after full peer‐review.
.
This article is linked to Valenti and Romeo paper. To view this article visit
https://doi.org/10.1111/apt.14154
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0003-2215-9410
0000-0002-2863-9389
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14119
PMID 28464257
PQID 1922444170
PQPubID 2045200
PageCount 8
ParticipantIDs proquest_miscellaneous_1894918366
proquest_journals_1922444170
pubmed_primary_28464257
crossref_citationtrail_10_1111_apt_14119
crossref_primary_10_1111_apt_14119
wiley_primary_10_1111_apt_14119_APT14119
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate July 2017
2017-07-00
2017-Jul
20170701
PublicationDateYYYYMMDD 2017-07-01
PublicationDate_xml – month: 07
  year: 2017
  text: July 2017
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Chichester
PublicationTitle Alimentary pharmacology & therapeutics
PublicationTitleAlternate Aliment Pharmacol Ther
PublicationYear 2017
Publisher Wiley Subscription Services, Inc
Publisher_xml – name: Wiley Subscription Services, Inc
References 2015; 13
2007; 17
2004; 101
2014; 514
2011; 334
2012; 142
2010; 59
2012; 486
1991; 12
2000; 25
2017; 65
2005; 41
2008; 57
2014; 46
2007; 50
2013; 8
2014; 111
2012; 56
2014; 61
2012; 55
2009; 49
2011; 7
2013; 19
2013; 57
2015; 62
2013; 12
2015; 61
2015; 42
2008; 49
2016; 65
2016; 64
2016; 63
2008; 21
2014; 39
2011; 140
2008; 40
2016; 291
2010; 7
2010; 51
2001; 96
1998; 282
2016; 150
2016; 44
e_1_2_7_5_1
e_1_2_7_3_1
e_1_2_7_9_1
e_1_2_7_7_1
e_1_2_7_19_1
e_1_2_7_17_1
e_1_2_7_15_1
e_1_2_7_41_1
e_1_2_7_13_1
e_1_2_7_43_1
e_1_2_7_11_1
e_1_2_7_45_1
e_1_2_7_47_1
e_1_2_7_26_1
e_1_2_7_49_1
e_1_2_7_28_1
Kohjima M (e_1_2_7_33_1) 2008; 21
e_1_2_7_50_1
e_1_2_7_25_1
e_1_2_7_31_1
e_1_2_7_23_1
e_1_2_7_21_1
e_1_2_7_35_1
e_1_2_7_37_1
e_1_2_7_39_1
e_1_2_7_6_1
e_1_2_7_4_1
e_1_2_7_8_1
e_1_2_7_18_1
e_1_2_7_16_1
e_1_2_7_40_1
e_1_2_7_2_1
e_1_2_7_14_1
e_1_2_7_42_1
e_1_2_7_12_1
e_1_2_7_44_1
e_1_2_7_10_1
e_1_2_7_46_1
e_1_2_7_48_1
e_1_2_7_27_1
e_1_2_7_29_1
e_1_2_7_51_1
e_1_2_7_30_1
e_1_2_7_24_1
e_1_2_7_32_1
e_1_2_7_22_1
e_1_2_7_34_1
e_1_2_7_20_1
e_1_2_7_36_1
e_1_2_7_38_1
28677287 - Aliment Pharmacol Ther. 2017 Aug;46(3):377-378
References_xml – volume: 63
  start-page: 764
  year: 2016
  end-page: 775
  article-title: The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
  publication-title: Hepatology
– volume: 41
  start-page: 1313
  year: 2005
  end-page: 1321
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 56
  start-page: 1363
  year: 2012
  end-page: 1370
  article-title: Non‐invasive diagnosis of non‐alcoholic steatohepatitis by combined serum biomarkers
  publication-title: J Hepatol
– volume: 12
  start-page: 162
  year: 1991
  end-page: 169
  article-title: Plasma endotoxin concentrations in patients with alcoholic and non‐alcoholic liver disease: reevaluation with an improved chromogenic assay
  publication-title: J Hepatol
– volume: 39
  start-page: 254
  year: 2014
  end-page: 269
  article-title: Systematic review with meta‐analysis: non‐invasive assessment of non‐alcoholic fatty liver disease–the role of transient elastography and plasma cytokeratin‐18 fragments
  publication-title: Aliment Pharmacol Ther
– volume: 25
  start-page: 187
  year: 2000
  end-page: 191
  article-title: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans
  publication-title: Nat Genet
– volume: 334
  start-page: 105
  year: 2011
  end-page: 108
  article-title: Linking long‐term dietary patterns with gut microbial enterotypes
  publication-title: Science
– volume: 514
  start-page: 508
  year: 2014
  end-page: 512
  article-title: High‐fat‐diet‐mediated dysbiosis promotes intestinal carcinogenesis independently of obesity
  publication-title: Nature
– volume: 8
  start-page: e62885
  year: 2013
  article-title: Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis–a longitudinal study
  publication-title: PLoS ONE
– volume: 57
  start-page: 1470
  year: 2008
  end-page: 1481
  article-title: Changes in gut microbiota control metabolic endotoxemia‐induced inflammation in high‐fat diet‐induced obesity and diabetes in mice
  publication-title: Diabetes
– volume: 96
  start-page: 1200
  year: 2001
  end-page: 1204
  article-title: Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis
  publication-title: Am J Gastroenterol
– volume: 7
  start-page: 15
  year: 2010
  article-title: Elevated endotoxin levels in non‐alcoholic fatty liver disease
  publication-title: J Inflamm (Lond)
– volume: 42
  start-page: 99
  year: 2015
  end-page: 105
  article-title: Patatin‐like phospholipase 3 (rs738409) gene polymorphism is associated with increased liver enzymes in obese adolescents and metabolic syndrome in all ages
  publication-title: Aliment Pharmacol Ther
– volume: 65
  start-page: 451
  year: 2017
  end-page: 464
  article-title: Gut microbiota profiling of pediatric NAFLD and obese patients unveiled by an integrated meta‐omics based approach
  publication-title: Hepatology
– volume: 39
  start-page: 532
  year: 2014
  end-page: 539
  article-title: PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
  publication-title: Aliment Pharmacol Ther
– volume: 40
  start-page: 1461
  year: 2008
  end-page: 1465
  article-title: Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
  publication-title: Nat Genet
– volume: 21
  start-page: 507
  year: 2008
  end-page: 511
  article-title: SREBP‐1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease
  publication-title: Int J Mol Med
– volume: 61
  start-page: 515
  year: 2015
  end-page: 525
  article-title: Genetic variation in transmembrane 6 superfamily member 2 and the risk of nonalcoholic fatty liver disease and histological disease severity
  publication-title: Hepatology
– volume: 51
  start-page: 454
  year: 2010
  end-page: 462
  article-title: Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 49
  start-page: 1877
  year: 2009
  end-page: 1887
  article-title: Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 111
  start-page: 8913
  year: 2014
  end-page: 8918
  article-title: TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content
  publication-title: Proc Natl Acad Sci USA
– volume: 61
  start-page: 708
  year: 2014
  end-page: 709
  article-title: Prevalence of the TM6SF2 variant and non‐alcoholic fatty liver disease in Chinese
  publication-title: J Hepatol
– volume: 291
  start-page: 10659
  year: 2016
  end-page: 10676
  article-title: Inactivation of Tm6sf2, a gene defective in fatty liver disease, impairs lipidation but not secretion of very low density lipoproteins
  publication-title: J Biol Chem
– volume: 7
  start-page: e1001324
  year: 2011
  article-title: Genome‐wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits
  publication-title: PLoS Genet
– volume: 13
  start-page: 643
  year: 2015
  end-page: 654
  article-title: Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta‐analysis of paired‐biopsy studies
  publication-title: Clin Gastroenterol Hepatol
– volume: 150
  start-page: 1208
  year: 2016
  end-page: 1218
  article-title: Hepatic transmembrane 6 superfamily member 2 regulates cholesterol metabolism in mice
  publication-title: Gastroenterology
– volume: 65
  start-page: 54
  year: 2017
  end-page: 64
  article-title: Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients
  publication-title: Hepatology
– volume: 59
  start-page: 969
  year: 2010
  end-page: 974
  article-title: Disease progression of non‐alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
  publication-title: Gut
– volume: 65
  start-page: 1359
  year: 2016
  end-page: 1368
  article-title: Screening diabetic patients for non‐alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
  publication-title: Gut
– volume: 19
  start-page: 6911
  year: 2013
  end-page: 6918
  article-title: Effects of probiotics on nonalcoholic fatty liver disease: a meta‐analysis
  publication-title: World J Gastroenterol
– volume: 61
  start-page: 506
  year: 2015
  end-page: 514
  article-title: Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease
  publication-title: Hepatology
– volume: 142
  start-page: 1100
  year: 2012
  end-page: 1101
  article-title: A high‐fat diet is associated with endotoxemia that originates from the gut
  publication-title: Gastroenterology
– volume: 140
  start-page: 976
  year: 2011
  end-page: 986
  article-title: Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency
  publication-title: Gastroenterology
– volume: 101
  start-page: 15718
  year: 2004
  end-page: 15723
  article-title: The gut microbiota as an environmental factor that regulates fat storage
  publication-title: Proc Natl Acad Sci USA
– volume: 49
  start-page: 821
  year: 2008
  end-page: 830
  article-title: Probiotics improve high fat diet‐induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells
  publication-title: J Hepatol
– volume: 50
  start-page: 2374
  year: 2007
  end-page: 2383
  article-title: Selective increases of bifidobacteria in gut microflora improve high‐fat‐diet‐induced diabetes in mice through a mechanism associated with endotoxaemia
  publication-title: Diabetologia
– volume: 42
  start-page: 731
  year: 2015
  end-page: 740
  article-title: Bacterial endotoxin and non‐alcoholic fatty liver disease in the general population: a prospective cohort study
  publication-title: Aliment Pharmacol Ther
– volume: 46
  start-page: 352
  year: 2014
  end-page: 356
  article-title: Exome‐wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
  publication-title: Nat Genet
– volume: 282
  start-page: 2085
  year: 1998
  end-page: 2088
  article-title: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene
  publication-title: Science
– volume: 46
  start-page: 345
  year: 2014
  end-page: 351
  article-title: Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
  publication-title: Nat Genet
– volume: 62
  start-page: 1742
  year: 2015
  end-page: 1756
  article-title: The dual and opposite role of the TM6SF2‐rs58542926 variant in protecting against cardiovascular disease and conferring risk for nonalcoholic fatty liver: A meta‐analysis
  publication-title: Hepatology
– volume: 44
  start-page: 1168
  year: 2016
  end-page: 1182
  article-title: Review article: novel methods for the treatment of non‐alcoholic steatohepatitis ‐ targeting the gut immune system to decrease the systemic inflammatory response without immune suppression
  publication-title: Aliment Pharmacol Ther
– volume: 55
  start-page: 2005
  year: 2012
  end-page: 2023
  article-title: The diagnosis and management of non‐alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
  publication-title: Hepatology
– volume: 12
  start-page: 256
  year: 2013
  end-page: 262
  article-title: Treatment of nonalcoholic steatohepatitis with probiotics. A proof‐of‐concept study
  publication-title: Ann Hepatol
– volume: 486
  start-page: 222
  year: 2012
  end-page: 227
  article-title: Human gut microbiome viewed across age and geography
  publication-title: Nature
– volume: 57
  start-page: 2525
  year: 2013
  end-page: 2531
  article-title: Dietary fructose in nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 64
  start-page: 34
  year: 2016
  end-page: 46
  article-title: Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
  publication-title: Hepatology
– volume: 57
  start-page: 601
  year: 2013
  end-page: 609
  article-title: Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH
  publication-title: Hepatology
– volume: 59
  start-page: 172
  year: 2010
  end-page: 181
  article-title: Experimental endotoxemia induces adipose inflammation and insulin resistance in humans
  publication-title: Diabetes
– volume: 17
  start-page: 1374
  year: 2007
  end-page: 1380
  article-title: Lipopolysaccharide‐binding protein plasma levels and liver TNF‐alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non‐alcoholic steatohepatitis
  publication-title: Obes Surg
– ident: e_1_2_7_51_1
  doi: 10.1038/nature11053
– ident: e_1_2_7_2_1
  doi: 10.1136/gutjnl-2015-309265
– ident: e_1_2_7_35_1
  doi: 10.1016/S1665-2681(19)31364-X
– ident: e_1_2_7_23_1
  doi: 10.1053/j.gastro.2016.01.005
– ident: e_1_2_7_25_1
  doi: 10.1111/apt.12569
– ident: e_1_2_7_21_1
  doi: 10.1073/pnas.1323785111
– ident: e_1_2_7_48_1
  doi: 10.1126/science.1208344
– ident: e_1_2_7_28_1
  doi: 10.1002/hep.23312
– ident: e_1_2_7_32_1
  doi: 10.1073/pnas.0407076101
– ident: e_1_2_7_31_1
  doi: 10.1111/j.1572-0241.2001.03702.x
– ident: e_1_2_7_47_1
  doi: 10.1074/jbc.M116.719955
– ident: e_1_2_7_16_1
  doi: 10.1111/apt.13327
– ident: e_1_2_7_29_1
  doi: 10.1016/j.jhep.2011.12.025
– ident: e_1_2_7_6_1
  doi: 10.1007/s11695-007-9243-7
– ident: e_1_2_7_45_1
  doi: 10.1002/hep.28142
– ident: e_1_2_7_44_1
  doi: 10.1002/hep.27556
– ident: e_1_2_7_27_1
  doi: 10.1002/hep.25762
– ident: e_1_2_7_19_1
  doi: 10.1111/apt.12609
– ident: e_1_2_7_39_1
  doi: 10.1038/76048
– ident: e_1_2_7_7_1
  doi: 10.1186/1476-9255-7-15
– ident: e_1_2_7_18_1
  doi: 10.1038/ng.257
– ident: e_1_2_7_4_1
  doi: 10.1136/gut.2009.205088
– ident: e_1_2_7_3_1
  doi: 10.1016/j.cgh.2014.04.014
– ident: e_1_2_7_46_1
  doi: 10.1002/hep.28475
– ident: e_1_2_7_12_1
  doi: 10.1002/hep.26299
– ident: e_1_2_7_5_1
  doi: 10.1371/journal.pgen.1001324
– ident: e_1_2_7_37_1
  doi: 10.1111/apt.13833
– ident: e_1_2_7_42_1
  doi: 10.1016/j.jhep.2014.04.047
– ident: e_1_2_7_41_1
  doi: 10.2337/db09-0367
– ident: e_1_2_7_17_1
  doi: 10.1038/ng.2901
– volume: 21
  start-page: 507
  year: 2008
  ident: e_1_2_7_33_1
  article-title: SREBP‐1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease
  publication-title: Int J Mol Med
– ident: e_1_2_7_9_1
  doi: 10.1002/hep.26093
– ident: e_1_2_7_11_1
  doi: 10.1002/hep.28572
– ident: e_1_2_7_13_1
  doi: 10.2337/db07-1403
– ident: e_1_2_7_30_1
  doi: 10.1002/hep.28356
– ident: e_1_2_7_26_1
  doi: 10.1002/hep.20701
– ident: e_1_2_7_14_1
  doi: 10.1002/hep.22848
– ident: e_1_2_7_50_1
  doi: 10.1053/j.gastro.2012.01.034
– ident: e_1_2_7_34_1
  doi: 10.1016/j.jhep.2008.05.025
– ident: e_1_2_7_43_1
  doi: 10.1002/hep.27490
– ident: e_1_2_7_24_1
  doi: 10.1002/hep.28697
– ident: e_1_2_7_20_1
  doi: 10.1111/apt.13232
– ident: e_1_2_7_38_1
  doi: 10.1111/j.1462-5822.2006.00796.x
– ident: e_1_2_7_40_1
  doi: 10.1007/s00125-007-0791-0
– ident: e_1_2_7_8_1
  doi: 10.1053/j.gastro.2010.11.049
– ident: e_1_2_7_15_1
  doi: 10.1016/0168-8278(91)90933-3
– ident: e_1_2_7_22_1
  doi: 10.1038/ng.2926
– ident: e_1_2_7_36_1
  doi: 10.3748/wjg.v19.i40.6911
– ident: e_1_2_7_10_1
  doi: 10.1371/journal.pone.0062885
– ident: e_1_2_7_49_1
  doi: 10.1038/nature13398
– reference: 28677287 - Aliment Pharmacol Ther. 2017 Aug;46(3):377-378
SSID ssj0006702
Score 2.4737291
Snippet Summary Background Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. Aim To test the hypothesis that...
Linked Content This article is linked to Valenti and Romeo paper. To view this article visit https://doi.org/10.1111/apt.14154 .
Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth. To test the hypothesis that endotoxemia is associated...
BackgroundPatients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.AimTo test the hypothesis that endotoxemia...
Patients with nonalcoholic steatohepatitis (NASH) have gut dysbiosis and intestinal bacterial overgrowth.BACKGROUNDPatients with nonalcoholic steatohepatitis...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 175
SubjectTerms Acute-Phase Proteins
Adult
Aged
Alanine
Alanine transaminase
Alleles
Aspartate aminotransferase
Biomarkers
Biopsy
Body mass
Body Mass Index
Carrier Proteins - blood
Cytokeratin
Dysbacteriosis
Endotoxemia
Endotoxemia - epidemiology
Fatty liver
Female
Fibrosis
Hemoglobin
Humans
Intestine
Intestines - microbiology
Keratin-18 - blood
Lipopolysaccharide-binding protein
Liver - pathology
Liver diseases
Male
Membrane Glycoproteins - blood
Middle Aged
Multivariate analysis
Non-alcoholic Fatty Liver Disease - epidemiology
Severity of Illness Index
Title Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fapt.14119
https://www.ncbi.nlm.nih.gov/pubmed/28464257
https://www.proquest.com/docview/1922444170
https://www.proquest.com/docview/1894918366
Volume 46
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1dT9swFLWqPiBeYDDYyjrkTTzwEkRix060JzSB2KZO0wCpD0iR7V1P0SCt1nRCPE3aH9hv5Jdw7TjhYyBNvFXKTZ3aPva58em5hGzt2lykNo8jm2RpxCW3UQbaVU01QuV41frSCaPP4vCEfxyn4x551_4XpvGH6F64OWT49doBXOnZLZCraY0wj73lp9NqOUL09cY6SkivN8QUI4-SLGbBVcipeLo77-5F_xDMu3zVbzgHy-S0fdRGZ_JjZ17rHXN5z8Xxib_lGVkKRJTuNTNnhfSgWiULo3DU_pz8OSq_V05HhF1PG2nXL6DqZjTpxFKoMKmdXMB5qah7o0u9fXFYTiluuuBq49GyogmTNHi4zprQalJd_f6rmhK9paFW1Rh65nQiNBwbrZGTg_3j94dRqNgQGebkUiZmWoBRyMIyyYBj-phJJYBJrtNYWMZ0DshhIDEy4YBULVZamSTHLBaYlWyd9LF1eEmo5THXgLekDEleylXK8at3gSFH-YbQHpDtduwKE-zMXVWNs6JNa7BTC9-pA_K2C502Hh4PBQ3bCVAEGM8KpL9If3gssbk33WUEoDtVURVM5hiT5TzHhVGIAXnRTJyuFdz7hVsU8WH98D_efLH35dh_2Pj_0FdkMXEkw4uHh6Rf_5zDa6RItd5ELHz4tOkRcQ1d8A6f
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1fT9UwFD8hkAgvoAJ6FbQQH3gZYWvXbokvxECuwiUELwkvZOnKqbkRdonsGuOTiV_Az-gn8bTrxh8lIb4t6enatT2nv9Oe_Q7Amy2by9TmcWSTLI2EEjbKsHRZU43UOZVanzphcCD7x-LDSXoyBW_bf2EafojuwM1phrfXTsHdgfQNLdeXNel57Dg_Z1xGb-9QHV2TR0nlIw7JycijJIt54BVycTxd1du70V8Q8zZi9VvO7gKctp1tIk0-b07qctN8v8Pj-L9f8xjmAxZl283ieQJTWD2FR4Nw274IPz-OPlUulIhGnzXRXV-R6esJZWPLsCK_dvwNL0aauUNd5hmMg0VltO-iS4_HRhVLuGKBxvWqEa3G1e8fv3STpXdkmNU1iZ67UBEWbo6W4Hh3Z_iuH4WkDZHhLmLKxLyUaDQBsUxxFORBZkpL5EqUaSwt52WOBGMwMSoRSGgt1qU2SU6OLHKr-DJMU-v4HJgVsSiRqqSccF4qdCro1VvICaackXb3YKOdvMIERnOXWOO8aD0bGtTCD2oP1jvRy4bG419CK-0KKIImXxWEgAkBiVhRc2tdMemgu1jRFY4nJJPlIifbKGUPnjUrp2uFtn_p7CJ11s___c0X24dD__Di4aKvYbY_HOwX--8P9l7CXOIwh48lXoHp-ssEVwkx1eUrrxh_AM13EcE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NTtwwEB4hKiEu9I_CAm3dikMvQZvYsRP1hKAr-gNCLUgckCLHjNGqkF1BFqGeKvUF-ox9EsaOEwotEuIWyePYsWfsb-zJNwCrfZvL1OZxZJMsjYQSNsqwdFlTjdQ5lVqfOmF7R27ti08H6cEUvG__hWn4IboDN2cZfr12Bj4-sn8ZuR7XZOaxo_x8JGQ_cyq9-fWaO0oqH3BIPkYeJVnMA62QC-Ppqt7cjP5BmDcBq99xBo_hsO1rE2jyfW1Sl2vmxy0axwd-zBOYC0iUrTeq8xSmsHoGM9vhrv05_Po2PK5cIBGNPWtiuy6Q6evpZCPLsCKvdnSJp0PN3JEu8_zFYT1ltOuiS47HhhVLuGKBxPW8Ea1G1Z-fv3WTo3domNU1iZ64QBEW7o3mYX_wYW9jKwopGyLDXbyUiXkp0WiCYZniKMh_zJSWyJUo01hazsscCcRgYlQikLBarEttkpzcWORW8RcwTa3jIjArYlEiVUk5obxU6FTQq_vICaQckW334F07d4UJfOYurcZJ0fo1NKiFH9QevO1Exw2Jx_-EVloFKIIdnxeEfwn_iFhRc2-6YrJAd62iKxxNSCbLRU4ro5Q9WGgUp2uFNn_pVkXqrJ_-u5sv1nf3_MPS_UVfw8zu5qD48nHn8zLMJg5w-EDiFZiuzyb4kuBSXb7yZnEFrm0QeQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Significant+positive+association+of+endotoxemia+with+histological+severity+in+237+patients+with+non%E2%80%90alcoholic+fatty+liver+disease&rft.jtitle=Alimentary+pharmacology+%26+therapeutics&rft.au=Pang%2C+J&rft.au=W+Xu&rft.au=Zhang%2C+X&rft.au=G+L%E2%80%90H+Wong&rft.date=2017-07-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0269-2813&rft.eissn=1365-2036&rft.volume=46&rft.issue=2&rft.spage=175&rft.epage=182&rft_id=info:doi/10.1111%2Fapt.14119&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-2813&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-2813&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-2813&client=summon